Francis Poulin

Francis Poulin is an experienced professional in analytical development with a focus on biologics and therapeutic advancements. Currently serving as Head of Analytical Development Biologics Late Stage at Takeda since December 2024, Poulin previously held the position of Vice President of Analytical Sciences at Sail Biomedicines from September 2021 to November 2024, where leadership of a high-performing team advanced programmable RNA medicines. Notable achievements include pioneering analytical methods for circular RNA and supporting successful regulatory interactions. Prior roles include Senior Director at Lyell Immunopharma, Scientific Director at Sanofi, and various positions at Genzyme, all contributing to extensive expertise in analytical development, quality control, and regulatory compliance. Educational background includes a PhD in Biochemistry from McGill University and a BS in Biochemistry from Université de Montréal.